PAVmed Inc. Gains 43.7%
Tue, Sep 10, 2024 at 05:30 PM
PAVmed Inc. (PAVM:NASDAQ) rocketted at $1.71, representing a gain of 43.7%. On Mon, Sep 09, 2024, PAVM:NASDAQ hit a New 2-Week High of $1.19. The stock got featured on our News Catalysts scanner on Tue, Sep 10, 2024 at 09:44 AM in the 'BIOTECH' category. From Mon, Aug 26, 2024, the stock recorded 55.56% Up Days and 70.00% Green Days
About PAVmed Inc. (PAVM:NASDAQ)
PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency.
Top 10 Gainers:
- Hempacco Co. Inc. (HPCO:NASDAQ), 1342.86%
- Oruka Therapeutics, Inc. (ABIO:NASDAQ), 1052%
- Quhuo Limited (QH:NASDAQ), 306.6%
- iLearningEngines Holdings Inc Cl A (AILE:NASDAQ), 115.11%
- BIO-key International, Inc. (BKYI:NASDAQ), 92.31%
- Trevena, Inc. (TRVN:NASDAQ), 53.73%
- FibroBiologics Inc. (FBLG:NASDAQ), 49.62%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 47.53%
- PAVmed Inc. (PAVM:NASDAQ), 43.7%
- LightInTheBox Holding Co., Ltd. (LITB:NYSE), 41.18%